Service Spotlight with Brian Castle
People ask me almost every day what makes Thought Leader Select different from the three dozen or so competitors we have in the thought leader services micro-niche within healthcare and biopharmaceuticals. Obviously, that’s a dangerous question to ask a marketing person! After all, I spend days on end composing multiple arguments to make the very case that we are uniquely positioned to help client companies in ways that many of our competitors haven’t even conceived.
What makes my job easy is that we are different. Very different, in fact. I know that lots of companies claim that their people are the difference, but that concept is especially true at Thought Leader Select. In addition to having a front-end consulting team with over 50 years of healthcare and biopharmaceutical industry experience, we have a back-end research team with over 50 years of clinical and research work in the field of medicine. Led by Lisa Smith, Clarissa Noureddine, Rhonda Napier, Lynda Scott, and Cammie Brannan, our research team delivers research assessments on the skills and experiences of thought leaders around the world.
Our team complements each assessment with technology tools (such our proprietary database, Thought Leader Index) and advisory capabilities that add an element to our work that other firms just can’t offer—elasticity. It’s one thing entirely to gather data for our clients, and it’s another thing altogether to be able to manipulate the data to offer real-life scenario-based solutions that spur action for better medical science consultations, conference presentations, and clinical and research advice from leading physicians and health care professionals around the world.
The key to this elasticity is our team’s ability to make each assessment live and breathe by adding breadth and depth after project completion. We affect the breadth and depth of an assessment by tying in additional thought leaders who bring a highly-specialized area of expertise, or by identifying thought leader expertise in areas that may not have been the core focus of the assessment (clients have this luxury when working with a team as thorough in its findings—no relevant stone left unturned—as the team at Thought Leader Select. Many companies count on this level of subject matter analysis that is truly a Thought Leader Select exclusive, a real competitive advantage over off-the-shelf biographical data and mapping solutions based on heavily-extrapolated survey responses. When our clients want to know who the right medical experts are for the right consultations, the choices are always clear.
In a world where each therapeutic area holds across-the-board leaders, highly-trained specialists, as well as rising stars who will lead the field for generations to come, biopharmaceutical and medical device companies need subject matter experts to guide them in engaging the right experts, at the right time and in the right way. If clients need to engage practicing clinicians, we have people (Noureddine) who have been practicing clinicians themselves. If clients need to engage researchers par excellence, we have medical researchers (Napier and Scott) providing analysis in that area. We even have a former investigative journalist (Smith) poring over the experience of medical experts in a variety of media venues. And no one, simply no one, knows thought leaders and their preferences for collaborating with the biopharmaceutical and device industries like Cammie Brannan.
We struggle to define these people, because their work surpasses definition on a regular basis. Are they researchers? Are they advisors? Are they subject matter experts? Are they the real consulting engine of our company? The answers to all of these questions is a resounding, “Yes.” So what should we call them? I prefer this moniker: The Difference-Makers. In the coming weeks, we’ll explore case studies that show the Thought Leader Select difference. Stay tuned!